New HHS head takes on swine flu

As news of the first American swine flu death--a 23-month-old baby in Texas--broke yesterday, the US Senate confirmed Kansas Governor Kathleen Sebelius's appointment to head the US Department of Health and Human Services (HHS), and she got right to work voicing the government's response to the potential pandemic. This morning (April 29), the new HHS secretary--backed by acting Center for Disease Control director Richard Besser, National Institute of Allergy and Infectious Diseases director Anth

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
As news of the first American swine flu death--a 23-month-old baby in Texas--broke yesterday, the US Senate confirmed Kansas Governor Kathleen Sebelius's appointment to head the US Department of Health and Human Services (HHS), and she got right to work voicing the government's response to the potential pandemic. This morning (April 29), the new HHS secretary--backed by acting Center for Disease Control director Richard Besser, National Institute of Allergy and Infectious Diseases director Anthony Fauci and others--gave her first press conference on swine flu. "We'll be working quickly, but safety is and will remain our top priority," Sebelius said in discussing the agency's efforts to formulate a vaccine to combat the new flu strain. She added that once a successful vaccine candidate is developed, the National Institutes of Health will quickly carry out clinical trials to assess safety and proper dosing of the drug. Meanwhile at Columbia University, bioinformatician linkurl:Raul Rabadan;http://wiki.c2b2.columbia.edu/rabadan/homepage/ and his colleagues compared the sequence data from the flu virus that has infected hundreds of people in Mexico and elsewhere to more than 10,000 virus sequences in the National Center for Biotechnology Information database. Contrary to some media reports that have characterized the current strain as a mixture of swine, avian, and human viruses, Rabadan said that the virus appears to be decidedly more swine-like. "The closest relatives to this virus are found in swine," Rabadan said, adding that most of the virus seems to be related to previously isolated swine virus in North America, but that another part of the virus seems to have Asian or European origins. Rabadan added that a part of the current virus may have evolved into a swine virus after a "triple reassortment" event--in which avian, human, and swine viruses combined in pigs-- that likely occurred in 1998, but that all segments of the current virus seem to be of swine origin. Though his results are preliminary, Rabadan's work is helping to form a more complete genetic picture of the new virus as vaccine development ramps up. A good genetic characterization of the novel virus, which is being transmitted from human-to-human and against which there appears to be no background immunity, will be crucial in the coming weeks. "We have not seen this before with this particular virus," Fauci said at the HHS press conference.
**__Related stories:__***linkurl:Can biotech tackle swine flu?;http://www.the-scientist.com/blog/display/55666/;
[27th April 2009]*linkurl:Vaccine dreams;http://www.the-scientist.com/article/display/54882/
[August 2008]*linkurl:From SARS to avian flu;http://www.the-scientist.com/article/display/15315/
[14th March 2005]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies